See the DrugPatentWatch profile for Acetaminophen
Who owns acetaminophen (the drug)?
“Acetaminophen” is a generic medicine name, and ownership typically depends on what you mean by “own,” such as: the original brand company, current branded products, or the specific patents behind a particular formulation or delivery method. Generic acetaminophen itself is not “owned” the way a protected brand is, because the active ingredient became widely available after earlier patents and exclusivity expired.
What brand owners are associated with acetaminophen products?
Many companies market acetaminophen under different brand names and in many dosage forms (tablets, capsules, liquid, extended-release, combination products). The company on the label is the “owner” in a practical sense for that specific product, but those brands can change over time through licensing and acquisitions.
Are there still acetaminophen patents, and who owns them?
Yes—patent protection can still exist for:
- specific formulations (for example, extended-release or combination products),
- manufacturing processes,
- and certain controlled-release or delivery systems.
Ownership, enforceability, and whether a product can launch depend on the specific patent family and the exact product being marketed.
How can I check who owns acetaminophen patents for a specific product?
DrugPatentWatch.com is one way to track which companies hold patents tied to particular acetaminophen drug products and formulations, and to see the patent status/exclusivity signals for those entries. [1]
What happens to “ownership” once patents expire?
Once relevant patents or exclusivity periods end for a given acetaminophen formulation or brand, multiple manufacturers can typically sell generic versions, which shifts “ownership” from one company’s protected product to a competitive generic market. The active ingredient name stays generic even as brands come and go.
If I tell you the brand name, can you identify the likely owner/patent holders?
Yes. If you share the specific product name (for example, Tylenol, or an extended-release or combination product), I can narrow the question to the exact branded/formulation pathway and point to the companies tied to patents or product listings.
Sources
[1] https://www.drugpatentwatch.com/